Navigation Links
Nventa Enrolls and Initiates Dosing of Final Cohort in HspE7 Phase 1 Cervical Dysplasia Trial
Date:3/11/2008

; William D. Kolton, M.D. of San Diego, California; Linda Roman, M.D. of the University of Southern California (USC); Michael L. Twede, M.D. of the Salt Lake Women's Center in Sandy, Utah; and Mark T. Saunders, M.D. at the Mt. Timpanogos Women's Healthcare/Physician's Research in Pleasant Grove, Utah.

About New HspE7:

The Company's lead candidate, new HspE7 (HspE7 + Poly-ICLC), is a novel therapeutic candidate intended for the treatment of precancerous and cancerous lesions caused by the human papillomavirus (HPV), one of the most common sexually transmitted diseases in the world. New HspE7 contains the novel CoVal(TM) fusion protein, HspE7 co-administered with the adjuvant, Poly-ICLC, a toll-like receptor-3 (TLR3) agonist adjuvant. An adjuvant is a substance added to vaccines to improve immune responses against target antigens. HspE7 is derived from Nventa's proprietary CoVal(TM) fusion platform, which uses recombinant DNA technology to covalently fuse stress proteins to target antigens, thereby stimulating cellular immune system responses. Nventa is developing new HspE7 for multiple indications.

About Nventa Corporation:

Nventa is developing innovative therapeutics for the treatment of viral infections and cancer, with a focus on diseases caused by the human papillomavirus (HPV). The corporation is publicly traded on the Toronto Stock Exchange under the symbol NVN. For more information about Nventa, please visit http://www.nventacorp.com.

This press release contains statements which may constitute forward-looking information under applicable Canadian securities legislation or forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking statements or information may include financial and other projections as well as statements regarding the Company's future plans, objectives, performance, revenues, gro
'/>"/>

SOURCE Nventa Biopharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Nventa Evaluation Complete for First Three Cohorts in HspE7 Phase 1 Cervical Dysplasia Trial
2. VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA-2291 to Reduce Vascular Inflammation
3. Spectranetics Enrolls First Patient in PATENT Trial for the Treatment of Instent Restenosis
4. Ception Therapeutics Initiates Phase II/III Clinical Trial for Its Lead Product Reslizumab in Eosinophilic Esophagitis (EE) in Children
5. Pharmacopeia Initiates Second Phase 2 Hypertension Study with PS433540 (DARA)
6. Phosphagenics Initiates U.S. Clinical Trials for Its Topical Retinoic Acid
7. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
8. Tigris Pharmaceuticals Initiates Phase I Study of AFP-464 in Patients with Solid Tumors
9. Nuvelo Initiates Phase 1 Clinical Trial of Thrombin Inhibitor, NU172
10. Northwestern Memorial Transplant Program Initiates New Study
11. Cerimon Pharmaceuticals Initiates Phase II/III Clinical Studies to Evaluate its Diclofenac Patch for Mild to Moderate Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... -- Codman Neuro*, part of DePuy Synthes Companies of ... embolic coils for the treatment of brain aneurysms, supported ... stability and provide an optimized detachment zone for coils ... Society of NeuroInterventional Surgery (SNIS) 12 th Annual ... finishing coils used during a minimally invasive endovascular procedure ...
(Date:7/28/2015)... , July 28, 2015  Insulet Corporation (NASDAQ: ... technology with its OmniPod ® Insulin Management System, ... been appointed to Insulet,s Board of Directors. ... healthcare experience to the Insulet Board. She currently serves ... Joslin Diabetes Center, the world,s largest diabetes research center, ...
(Date:7/28/2015)... Colo. , July 28, 2015   ... the "Company"), a provider of  advanced veterinary diagnostic ... the availability of the new Element i ® ... testing and screening for key health concerns, including ... Element i is a compact bench top analyzer ...
Breaking Medicine Technology:Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 2Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 3Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 4Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 2Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 3Heska Announces Veterinary Market's first and only point of care Analyzer for TSH, Total T4, and Cortisol results in minutes 2Heska Announces Veterinary Market's first and only point of care Analyzer for TSH, Total T4, and Cortisol results in minutes 3
... Leading health sciences publisher makes key ... UN developing world research access program ... information products and services, today announced that it is ... , a public-private partnership working to achieve the UN,s ...
... (NASDAQ: LMNX ) today announced that it expects ... on Tuesday, November 1, 2011.  A press release announcing ... of trading. (Logo:   http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) ... the operating highlights and financial results for the third quarter ...
Cached Medicine Technology:Elsevier Offers 950 New Health Titles to Research4Life 2Elsevier Offers 950 New Health Titles to Research4Life 3Luminex Corporation Third Quarter Earnings Release Scheduled for November 1, 2011 2Luminex Corporation Third Quarter Earnings Release Scheduled for November 1, 2011 3
(Date:7/29/2015)... IL (PRWEB) , ... July 29, 2015 , ... People ... benefit from two new products on Mercola.com: a vertical “garden tower” and enhanced mineral ... can be squeezed into small corners on a porch, balcony, or rooftop – can ...
(Date:7/29/2015)... ... July 29, 2015 , ... One of the world’s leading ... the potentially lifesaving impact of removing aluminum from Alzheimer’s disease patients, announced the ... is based on a successful pilot study published in The Journal of Alzheimer’s ...
(Date:7/29/2015)... ... July 29, 2015 , ... EndoMune Advanced ... chewable version of its EndoMune Jr. probiotic supplement for children ages 3-8. , ... children can enjoy to maintain a healthy balance of beneficial gut bacteria,” said ...
(Date:7/29/2015)... ... ... One may not expect to encounter a kickball game or the sound ... happening on the campus of Piedmont Crossing , a local 60-acre retirement community. ... , a five-star childcare center which operates on the same campus. As many as ...
(Date:7/29/2015)... ... July 29, 2015 , ... Nature’s Artisan, a new holistic ... gourmet flavors. , Nature’s Artisan was founded by Tina Yarandi, who came up with ... UCLA School of Dentistry. Tina was amazed when she learned about the incredible dental ...
Breaking Medicine News(10 mins):Health News:Mercola.com Introduces NEW Garden Tower and Enhanced Mineral Solution for Healthy Plants 2Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 2Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 3Health News:EndoMune Advanced Probiotic adds Chewable Tablet for Kids to Product Line 2Health News:EndoMune Advanced Probiotic adds Chewable Tablet for Kids to Product Line 3Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 2Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 3Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 4Health News:Discover a New Take on Oral Care with Nature’s Artisan Gourmet Mouthwashes 2
... and interactions between noncoding genes play a much greater ... research, published by Cell Press in the September issue ... identifying tumor-specific signatures associated with diagnosis, prognosis, and treatment ... oncogenes or tumor suppressor genes. More recently, a large ...
... implanted in the skull that detects oncoming seizures, then delivers ... is under study at the Medical College of Georgia. , ... to determine if the neurostimulator device can help patients whose ... constantly monitors electrical activity of the brain, gets accustomed to ...
... LINDA, Calif., Sept. 10 Loma Linda ... Adventist institution located,in Southern California, has chosen ... referrals and outbound reminder calls for its ... physician referrals for breast care, psychology, urology,gynecology, ...
... entries reveal wellness trends of on-staff pharmacists, ... a focus on healthy aging, CHICAGO, Sept. ... the third-annual Health at Work Award: Sprint; Erie ... Library District. Winners,were selected based on their wellness ...
... Merger and Manage Company Company Announces ... 10 Arrow International,Inc. (Nasdaq: ARRO ), a ... critical and cardiac care, reported that Glass,Lewis & Co., ... to,approve Arrow,s planned $45.50 merger with Teleflex Incorporated (NYSE:,TFX) ...
... Robbins & Myers, Inc.,(NYSE: RBN ) announced ... year results for 2007, which ended August 31, 2007, ... live webcast of the conference call,will be held at ... Robbins & Myers will be Peter C. Wallace, President ...
Cached Medicine News:Health News:Altered expression of ultraconserved noncoding RNAs linked to human leukemias and carcinomas 2Health News:Implantable device designed to detect, stop seizures under study at MCG 2Health News:Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Women's Services Programs and Departments 2Health News:ComPsych(R) Corp. Announces Health at Work(SM) Award Winners: Sprint, Erie Insurance, City of Naperville and Green Hills Public Library 2Health News:Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting 2Health News:Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting 3
... 420 CPAP System is the smallest and ... on the market. It is designed to ... lifestyles while complying with therapy. The GoodKnight ... of date/time usage data. It also detects ...
Micro-hematocrit tubes available in multiple sizes and additives for a wide range of capillary blood collection....
... VH IVUS technology uses advanced spectral ... of ultrasound images and provide detailed ... patient's atherosclerotic plaques. The colorized VH ... fibrous, fibro-fatty, dense calcium, and necrotic ...
... the GE Innova 2100IQ: See the finest ... Place interventional devices. Its all enabled by ... that helps deliver excellent image quality and ... family systems installed worldwide, more physicians rely ...
Medicine Products: